Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Demand & Sales Analysis by Product Type & End-User The global ultrasound gel market will witness a robust CAGR of 9.23%, valued at $3.93 billion in 2021, expected to appreciate and reach $8.7 billion by 2030, confirms Strategic Market Research. World Health Organization (WHO) in 2018 stated that diagnostic ultrasound is used during pregnancy to diagnose problems related to fetal growth and other clinical complications such as any genetic condition. Key Drivers - Low Cost, Convenience, Used for Multiple Diagnoses Factors such as the low cost of ultrasound gels, their convenience of use, and fewer side effects are projected to support ultrasound gel market share growth. The diagnoses of renal, gallbladder, cancer, and intestinal illnesses further fuel the industry's growth. Restraints - The Cooling Effect, Limited Resources The cooling effect of ultrasound gels and a lack of healthcare resources are expected to limit the overall industry growth. Opportunities The expansion in the number of ultrasound units in clinics and the easy availability of handheld ultrasound devices at low rates have boosted their acceptance rate in small clinics and hospitals, and hence the market is expected to develop significantly in the future. Market Analysis Of Different Segments Covered in the Report The market has been broadly segmented based on Type, End-user, and region. Based on Type Sterile Non-Sterile Based on End-User Hospitals and clinic Specialized Cardiovascular Disease Treatment Centres Ambulatory surgery centers Regional Coverage Analysis Based on Region North America Europe Asia-Pacific Middle-East and Africa Latin America Segments Analysis & Insights By Type, Non-sterile ultrasound gel had the highest revenue share (71.0%). On the other hand, the sterile ultrasonic gel segment is predicted to increase at the fastest rate. By End-User, the Hospital segment accounted for 53.5 percent of total revenue and was expected to rise sharply over the projection period. The need for ultrasound gels is predicted to rise as emergency room visits for illnesses like acute abdominal pain, chest discomfort, and vascular disorders, where ultrasound is the major diagnostic tool. North America is projected to have the largest market due to favorable healthcare infrastructure, rising prevalence of chronic diseases, the scope for innovation, strong presence of major market players, better healthcare infrastructure, and fair reimbursement policies. Because of government initiatives, growing public awareness, government initiatives toward healthcare, and increased investment in the industry in India, Asia-Pacific is predicted to have ultrasound gel as the fastest-growing market. Ultrasound Gel Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 3.63 Billion The revenue forecast in 2030 USD 8.7 Billion Growth rate CAGR of approximately 9.23% The base year for estimation 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By End-user, By Region By Type Sterile, Non-Sterile By End-user Hospitals and clinics, Specialized Cardiovascular Disease Treatment Centres, Ambulatory surgery centres By Region Asia Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Parker Laboratories, OrthoCanada, Medline Industries, Dr Reddy's Lab, Cardinal Health Inc, Phyto Performance, DNP Enterprise, Sonogel Vertriebs GmbH., Nissha Medical Technologies., Unique International. Ultrasound Gel Market Competitive Landscape Analysis The global industry report contains a thorough competitive landscape analysis, which details the most significant competitors operating in the global market. The comparison is based on overall revenue generation, market initiatives, company overview, R&D investment, production analysis, value chain optimization, market share financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, and other variables. Parker Laboratories OrthoCanada Medline Industries Dr. Reddy's Lab Cardinal Health Inc Phyto Performance DNP Enterprise Sonogel Vertriebs GmbH. Nissha Medical Technologies. Unique International Recent Developments In May 2021, The American Institute of Ultrasound in Medicine released a statement in May 2021 about the use of polyethylene glycol (peg) in ultrasound contrast agents. In March 2021, HR Pharmaceuticals announced the expansion of its EcoVue product range with the introduction of EcoVue HV Ultrasound Gel, a high-viscosity recipe that is 35% thicker than the original formula. In addition, users may select the ideal viscosity based on the technique with this service. SonoClear, a new acoustic coupling fluid from a start-up, was registered for clinical studies in February 2021 to evaluate its performance and safety. This coupling fluid can replicate normal brain waves. Various Devices that Key Market Leaders Develop Product Function Key players AQUASONIC CLEAR, SCAN For diagnostic and therapeutic medical ultrasound procedures. Parker Laboratories Wavelength MP therapeutic ultrasound, shockwave therapy, diagnostic imaging, and other external procedures OrthoCanada Scan Ultrasound Gel not stain clothing, damage equipment, or irritate the skin. Cardinal Health Inc Safergel Sterile ultrasound gel Safersonic EcoVue Gel with 99% naturally fermented ingredients, Nissha Medical Technologies. Frequently Asked Question About This Report How big is the ultrasound gels market? The global ultrasound gels market size was around $3.93 million in 2021 and is predicted to reach $4.29 million in 2022. Which are the top 5 countries driving demand for ultrasound gels? The Ultrasound Gel Market Forecast suggests that demand for ultrasound conductivity gels is likely to be driven by the United States, India, Australia, Germany, and Italy. Why is blue gel used for an ultrasound? The blue gel provides frictionless film without air bubbles so that sound waves can penetrate the penetrate body easily. On which organs we could do the ultrasound? Ultrasound examines the bodys internal organs, including the heart, liver, kidney, gall bladder, reproductive organs like the uterus and other chronic diseases using doppler ultrasound gel. The gel is available at ultrasound gel CVS Stores. What is the ultrasound gel market growth? The global ultrasound gel market is expected to grow at a compound annual growth rate (CAGR) of 9.23% from 2021 to 2030 to reach USD 8.7 billion by 2030. . Sources https://www.aium.org/ https://hrpharma.com/ http://www.who.int/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Ultrasound Gel Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by Region, 2021 - 2030 (USD Million) 4.4 Type Business Analysis 4.4.1 Global Market, By Type, 2021 - 2030 (USD Million) 4.5 End-User Business Analysis 4.5.1 Global Market, By End-User, 2021 - 2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Ultrasound Gel Manufacturing Sites, Area Served, Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Sterile 7.3.1. Sterile market, 2021 - 2030 (USD Million) 7.4. Non-Sterile 7.4.1. Non-Sterile market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and clinic 8.3.1. Hospitals and clinic market, 2021 - 2030 (USD Million) 8.4. Specialized Cardiovascular Disease Treatment Centers 8.4.1. Specialized Cardiovascular Disease Treatment Centers market, 2021 - 2030 (USD Million) 8.5 Ambulatory surgery centers 8.5.1 Ambulatory surgery centers market, 2021 - 2030 (USD Million) 9. Global Ultrasound Gel Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By Type, 2021 - 2030 (USD Million) 9.1.4. North America Market, By End-User, 2021 - 2030 (USD Million) 9.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By Type, 2021 - 2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By Type, 2021 - 2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021 - 2030 (USD Million) 9.1.4.2.3. Canada Market, by End-Users, 2021 - 2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By Type, 2021 - 2030 (USD Million) 9.2.2. Europe Market, by By End-User, 2021 - 2030 (USD Million) 9.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By Type, 2021 - 2030 (USD Million) 9.2.4.1.2. U.K. Market, By End-Users, 2021 - 2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021 - 2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By Type, 2021 - 2030 (USD Million) 9.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021 - 2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By Type, 2021 - 2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021 - 2030 (USD Million) 9.2.4.3.3. France Market, by End-User, 2021 - 2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By Type, 2021 - 2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021 - 2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By Type, 2021 - 2030 (USD Million) 9.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By Type, 2021 - 2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021 - 2030 (USD Million) 9.3.4.1.3. China Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By Type, 2021 - 2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021 - 2030 (USD Million) 9.3.4.2.3. India Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By Type, 2021 - 2030 (USD Million) 9.3.4.3.3. Japan Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By Type, 2021 - 2030 (USD Million) 9.3.4.4.3. South Korea Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By Type, 2021 - 2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, by End-User, 2021 - 2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By Type, 2021 - 2030 (USD Million) 9.4.3. Latin America Market, by End-User, 2021 - 2030 (USD Million) 9.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By Type, 2021 - 2030 (USD Million) 9.4.4.1.3. Brazil Market, by End-User, 2021 - 2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By Type, 2021 - 2030 (USD Million) 9.4.4.2.3. Mexico Market, by End-User, 2021 - 2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Market, By Type, 2021 - 2030 (USD Million) 9.4.4.3.3. Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) 9.5. MEA 9.5.1. MEA Market, By Type, 2021 - 2030 (USD Million) 9.5.3. MEA Market, by End-User, 2021 - 2030 (USD Million) 10. Competitive Landscape 10.1 Parker Laboratories. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Product Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Ortho Canada. 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. Medline Industries. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Dr Reddy’s Lab. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Cardinal Health Inc 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. Phyto Performance. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. DNP Enterprise. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. SonogelVertriebs GmbH. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Nissha Medical Technologies. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Unique International. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development List of Tables (41 Tables) TABLE 1. Market, By Type, 2021-2030 (USD Million) TABLE 2. Market FOR Sterile, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Non-Sterile, BY REGION, 2021-2030 (USD Million) TABLE 4. Market, BY END-USER, 2021-2030 (USD Million) TABLE 5. Market FOR Hospitals and clinic, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Specialized Cardiovascular Disease Treatment Centers, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Ambulatory surgery centers, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, BY REGION, 2021-2030 (USD Million) TABLE 9. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 10. NORTH AMERICA Market, BY End-Users, 2021-2030 (USD Million) TABLE 11. NORTH AMERICA Market, By Type, 2021-2030 (USD Million) TABLE 12. NORTH AMERICA Market, BY END-USER, 2021-2030 (USD Million) TABLE 13. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 14. EUROPE Market, By Type, 2021-2030 (USD Million) TABLE 15. EUROPE Market, BY END-USER, 2021-2030 (USD Million) TABLE 16. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 17. ASIA-PACIFIC Market, By Type, 2021-2030 (USD Million) TABLE 18. ASIA-PACIFIC Market, BY END-USER, 2021-2030 (USD Million) TABLE 19. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 20. LAMEA Market, By Type, 2021-2030 (USD Million) TABLE 21. LAMEA Market, BY END-USER, 2021-2030 (USD Million) TABLE 22. Parker Laboratories: COMPANY SNAPSHOT TABLE 23. Parker Laboratories: OPERATING SEGMENTS TABLE 24. Ortho Canada: COMPANY SNAPSHOT TABLE 25. Ortho Canada: OPERATING SEGMENTS TABLE 26. Medline Industries: COMPANY SNAPSHOT TABLE 27. Medline Industries: OPERATING SEGMENTS TABLE 28. Dr Reddy’s Lab: COMPANY SNAPSHOT TABLE 29. Dr Reddy’s Lab: OPERATING SEGMENTS TABLE 30. Cardinal Health Inc: COMPANY SNAPSHOT TABLE 31. Cardinal Health Inc: OPERATING SEGMENTS TABLE 32. Phyto Performance: COMPANY SNAPSHOT TABLE 33. Phyto Performance: OPERATING SEGMENTS TABLE 34. DNP Enterprise: COMPANY SNAPSHOT TABLE 35. DNP Enterprise: OPERATING SEGMENTS TABLE 36. SonogelVertriebs GmbH: COMPANY SNAPSHOT TABLE 37. SonogelVertriebs GmbH: OPERATING SEGMENTS TABLE 38. Nissha Medical Technologies: COMPANY SNAPSHOT TABLE 39. Nissha Medical Technologies: OPERATING SEGMENTS TABLE 40. Unique International: COMPANY SNAPSHOT TABLE 41. Unique International: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 10 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Ultrasound Gel, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Ultrasound Gel, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11Market, By End-Users, 2019 vs. 2025 (USD Million) Figure 12Market Share, By Type, 2019 vs. 2025 Figure 13 Geographical Snapshot of the Market Figure 14 Non-Sterile to Witness Higher CAGR in Market for TypeSegment during Forecast Period. Figure Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 16 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 17Market: Drivers, Restraints, Opportunities, and Challenges Figure 18 North America: Market Snapshot Figure 19 Asia Pacific: Market Snapshot Figure 20 Vendor Dive: Evaluation Overview